Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Derivatives of Graphene Oxide as Potential Drug Carriers.

Kozik V, Bak A, Pentak D, Hachula B, Pytlakowska K, Rojkiewicz M, Jampilek J, Sieron K, Jazowiecka-Rakus J, Sochanik A.

J Nanosci Nanotechnol. 2019 May 1;19(5):2489-2492. doi: 10.1166/jnn.2019.15855.

PMID:
30501744
2.

Proteomic and Functional Analyses of the Virion Transmembrane Proteome of Cyprinid Herpesvirus 3.

Vancsok C, Peñaranda MMD, Raj VS, Leroy B, Jazowiecka-Rakus J, Boutier M, Gao Y, Wilkie GS, Suárez NM, Wattiez R, Gillet L, Davison AJ, Vanderplasschen AFC.

J Virol. 2017 Oct 13;91(21). pii: e01209-17. doi: 10.1128/JVI.01209-17. Print 2017 Nov 1.

3.

Conserved Fever Pathways across Vertebrates: A Herpesvirus Expressed Decoy TNF-α Receptor Delays Behavioral Fever in Fish.

Rakus K, Ronsmans M, Forlenza M, Boutier M, Piazzon MC, Jazowiecka-Rakus J, Gatherer D, Athanasiadis A, Farnir F, Davison AJ, Boudinot P, Michiels T, Wiegertjes GF, Vanderplasschen A.

Cell Host Microbe. 2017 Feb 8;21(2):244-253. doi: 10.1016/j.chom.2017.01.010.

4.

Cyprinid Herpesvirus 3: An Archetype of Fish Alloherpesviruses.

Boutier M, Ronsmans M, Rakus K, Jazowiecka-Rakus J, Vancsok C, Morvan L, Peñaranda MM, Stone DM, Way K, van Beurden SJ, Davison AJ, Vanderplasschen A.

Adv Virus Res. 2015;93:161-256. doi: 10.1016/bs.aivir.2015.03.001. Epub 2015 Apr 29. Review.

5.

Cyprinid herpesvirus 3: an interesting virus for applied and fundamental research.

Rakus K, Ouyang P, Boutier M, Ronsmans M, Reschner A, Vancsok C, Jazowiecka-Rakus J, Vanderplasschen A.

Vet Res. 2013 Sep 27;44:85. doi: 10.1186/1297-9716-44-85. Review.

6.

Vasostatin increases oxygenation of B16-F10 melanoma tumors and raises therapeutic efficacy of cyclophosphamide.

Cichoń T, Jarosz M, Smolarczyk R, Ogórek B, Matuszczak S, Wagner M, Mitrus I, Sochanik A, Jazowiecka-Rakus J, Szala S.

Acta Biochim Pol. 2012;59(3):377-81. Epub 2012 Sep 3.

7.

Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.

Jarosz M, Jazowiecka-Rakus J, Cichoń T, Głowala-Kosińska M, Smolarczyk R, Smagur A, Malina S, Sochanik A, Szala S.

Gene Ther. 2013 Mar;20(3):262-73. doi: 10.1038/gt.2012.28. Epub 2012 Apr 12.

PMID:
22495576
8.

Combination of vasostatin and cyclophosphamide in the therapy of murine melanoma tumors.

Jazowiecka-Rakus J, Jarosz M, Kozłowska D, Sochanik A, Szala S.

Acta Biochim Pol. 2007;54(1):125-33. Epub 2007 Mar 20.

9.

Gene expression profile of B 16(F10) murine melanoma cells exposed to hypoxic conditions in vitro.

Olbryt M, Jarzab M, Jazowiecka-Rakus J, Simek K, Szala S, Sochanik A.

Gene Expr. 2006;13(3):191-203.

10.

Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.

Jazowiecka-Rakus J, Jarosz M, Szala S.

Acta Biochim Pol. 2006;53(1):199-202. Epub 2005 Dec 21.

11.

Antitumour activity of Salmonella typhimurium VNP20047 in B16(F10) murine melanoma model.

Jazowiecka-Rakus J, Szala S.

Acta Biochim Pol. 2004;51(3):851-6.

12.

In vivo gene transfer using cetylated polyethylenimine.

Sochanik A, Cichoń T, Makselon M, Strózyk M, Smolarczyk R, Jazowiecka-Rakus J, Szala S.

Acta Biochim Pol. 2004;51(3):693-702.

Supplemental Content

Loading ...
Support Center